Fine-tuning Compliance: From Traditional Compounding (503A) to Outsourcing Facilities (503B)
The enactment of the Drug Quality and Security Act distinguishes between two types of compounding pharmacies: traditional compounding pharmacies (503A) and outsourcing facilities (503B). If you currently own a compounding practice, deciding which of these two categories to operate under can be a challenge. Indeed, pharmacies currently operating as a 503A may want to transition into a 503B or may want to integrate standards of practice required by a 503B to stay ahead of the curve and to promote their commitment to quality as a competitive advantage.
This webinar will focus on the fundamental difference between verification (required for traditional compounding pharmacies) and validation (required by outsourcing facilities) with a focus on its applicability to environmental and personnel management. Distinctions will also be made between preparation and product processing.
Understanding the differences in these fundamental concepts is the stepping-stone toward making informed decisions about your compounding pharmacy. By attending this webinar, you will be provided with the tools and knowledge needed to improve your pharmacy while maintaining compliance. Join us and we will show you the way for today, tomorrow, and into the future.
This webinar is sponsored by MEDISCA Network
- QA/QC Specialists
- Compliance Specialists
- Pharmacy Managers
- Auditors and Inspectors
- Evaluate the advantages and disadvantages of a 503A and 503B practice.
- Differentiate between verification and validation.
- Understand environmental and personnel management requirements for the 503A and 503B practice.
- Understand compounded preparations and drug product processing for the 503A and 503B practice.
High speed internet connectivity and an updated internet browser is required to attend the webinar. The broadband recommended is 1 Mbps or better. The minimum browser requirements to attend the webinar are:
- Google Chrome v39 or later
- Mozilla Firefox v34 or later
- Internet Explorer v8 or later
- Microsoft Edge
- Apple Safari v6 or later
|KEN SPEIDEL, BS Pharm, PharmD, RPh, FIACP, FACA|
Senior Associate, Gates Healthcare Associates
Disclosure: Accreditation Commission for Health Care (ACHC), Surveyor; Gates Healthcare Associates, Consultant; MEDISCA, Consultant
Dr. Ken Speidel is known for his experience in pharmacy practice and education, including his national recognition as a pharmacotherapeutic specialist in endocrinology and pain management, as well expertise in sterile and non-sterile compounding processes. He has been instrumental in the development of national standards for pharmacy compounding practices and provides consulting services to many organizations including boards of pharmacy as well as hospitals and health systems in the United States and abroad.
Concurrent with his worldwide consulting and educational work, Dr. Speidel recently retired as a Professor of Pharmacy Practice. He has also assisted in the development and facilitation of many nationally recognized ACPE educational programs. Moreover, Ken was an advisor for the development of the Pharmacy Compounding Accreditation Board (PCAB) and remains an active surveyor and accreditation expert for PCAB/ACHC (Accreditation Commission for Health Care). He has also served as president of the National Home Infusion Association (NHIA) as well as president of large hospice program in the United States.
Dr. Speidel received a Bachelor of Science and Doctor of Pharmacy from Ohio Northern University. He has been awarded Fellowship status with the International Academy of Compounding Pharmacists as well as the American College of Apothecaries.